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Abstract 
Saffron extracts have a long history of application as skin protectant, possibly due to their ability to scavenge 
free  radicals. In this work, the performance of a hydrogel enriched with antioxidant compounds isolated from 
saffron crocus (Crocus sativus L.) petals was tested. These  hydrogels could be considered as new drug delivery 
system. Hydrogels are crosslinked polymer networks that absorb large quantities of water but retain the 
properties of a solid, thus making ideal dressings for sensitive skin. We tested antioxidant-enriched 
hydrogels on primary mouse fibroblasts. Hydrogels enriched with kaempferol and crocin extracted from 
saffron petals showed good biocompatibility with in vitro cultured fibroblasts. These new types of hydrogels 
may find applications in wound treatment and/or beautification. 
 
Introduction 
Since ancient times, saffron threads (the dried stigmas of the saffron crocus, Crocus sativus L.) have 
been widely used as a flavour enhancer in food, as a tonic, an appe- tizer, or as a digestive. 
Moreover, in the areas of its culti- vation, saffron has found applications in some medicinal 
preparations used to treat colds, cardiovascular disorders, and ocular disorders [1, 2]. Currently, the 
petals of saffron flowers are discarded as waste material, though their chemical profile is similar to 
that of the stigmas [3]. It has been shown that saffron petals are rich in several antioxi- dant 
compounds like flavonols and flavanones [4], but contain less crocin [5]. The antioxidants have 
been con- sidered as the active ingredients responsible for a variety of health-enhancing properties 
that were traditionally at- tributed to saffron. This study focuses mainly on 2 anti- oxidant 
compounds, crocin and kaempferol, that are among the key natural antioxidants in the human 
 
diet, and are widely assumed to contribute to the health-en- hancing effect of fruits and vegetables 
[6–8]. Crocin, the main pigment of C. sativus stigmas, and the most abun- dant compound in saffron 
spice, has also been identified  
 
 
Fig. 1. Mouse fibroblasts after 14 days of growth in the presence of hydrogel with hy- drogel without 
compounds  (a,  control),  2 mg/mL kaempferol (b), or 2 mg/mL cro- cin (c). The clear area is where 
the presence of the hydrogel formed a physical barrier that prevented cell invasion. All cells have a 
normal, healthy appearance. 
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in petals of the saffron crocus [9, 10]. Kaempferol and related flavonols, like quercetin, have received 
consider- able interest because of their antioxidant properties and their potential role in 
chemoprotection [11–13]. Kaemp- ferol is a well-studied flavonol and has been identified in a range of 
fruits and vegetables. Recently, petals of C. sa- tivus have been shown to be a particularly rich source 
of kaempferol glycosides [14, 15]. The total amount of gly- cosides in petal extracts was established 
by quantifying the amount of aglycone after hydrolysis. The amount of free kaempferol aglycone 
detectable before hydrolysis was negligible [16]. The aim of this study was to explore the potential of 
C. sativus petals as a possible source of antioxidants and chemopreventive compounds for use in 
hydrogels. These hydrogels could be considered an easy, cheap, enriched delivery system for 
applications either in treatment of difficult wounds or in wound healing masks and beauty masks as 
well [13, 17]. 
 
Materials and Methods 
Hydrogels are structures capable of swelling and absorbing a large amount of water. They have the 
capacity to retain properties of a solid due to the presence of crosslinked networks between the 
macromolecular chains. Many naturally occurring polymers form hydrogels, e.g. poly-N68 
acetylglucosamine in bacterial biofilms [18], hyaluronate in extracellular matrix components, agarose 
from seaweed, or glucomannans [β-(1,4)-acetylated mannan] from Aloe vera. Because of their 
outstanding capacity to retain at least 90% of water, hydrogels have been investigated for different 
biological purposes, e.g. delivery systems for drugs [19] and/or as improved dressing of wounds [20], 
 
and more recently in laser-as- sisted dental surgery [21]. In the present work, a hydrogel is com- 
posed by mixing an aqueous solution with 2 sets of biocompatible synthetic polymers, i.e. polyvinyl 
pyrrolidone and polyethylene glycol, and agar polysaccharide for jellification. The hydrogel was 
sterilized before use by gamma radiation at 25 kGy [22]. Three separate solutions were prepared 
consisting of 60 g polyvinyl pyr- rolidone + 6 g agar + 12 mL polyethylene glycol 200 made up to a 
total volume of 600 mL with distilled water: i.e. the control solution contained just water, the 2 test 
solutions were made with water containing 160 mg/L of respectively kaempferol or crocin. The pu- rity 





The hydrogels all appeared clear and were colourless, yellow, and dark orange, respectively, for control, 
kaemp- ferol, and crocin. The objective of the in vitro test is to assess whether or not the biomaterial 
interface is toxic for mammalian cells. Since it is composed of a large quantity of water, the hydrogel is 
well tolerated by the skin. We chose fibroblasts (connective tissue cells) from newborn mice as a model 
for skin. This cell type grows readily in culture, and is best suited for changing environmental conditions, 
which is why it is most commonly used for experimental purposes [20]. The objective of the test is to 
estimate the cytotoxicity degree of a material for biomed- ical use, obtaining a rapid response as 
preliminary prepa- ration for future in vivo application [26]. Mice were sac- rificed with cervical dislocation. 
Fibroblasts were ob- tained by fragmenting the mouse connective tissue with sterile scissors and scalpel, 
finally digesting the tissue with trypsin. To prepare working solutions, 1.0 mL of trypsin (purchased in 2.5× 
concentrated) was mixed with 1.0 mL of foetal bovine serum. The isolated fibroblasts were grown, in Petri 
dishes of 24 and 36 cm2, in Dulbecco’s modified Eagle’s medium supplemented with among others 10% 
(v/v) heat-inactivated foetal bovine serum, glutamine, and gentamycin. Cultures were maintained at 37°C 
in humidified air with 5% CO2. At fixed deadlines, i.e. on the 3rd, 7th, and 14th days after reaching at 
least 80% cell confluence, all cultures were coloured using the Wright method for cell counting and 
other morphologi- cal evaluations. Figure 1 shows the results of the compat- ibility tests. From the 
microscopic images, supported by the cell density with the Image J programme, it can be seen 
that fibroblasts grow all the way up to the hydrogel, which presents a physical barrier that prevents 
invasion by the growing tissue. No cell-free zone of inhibition is observed, and no indications can 
be found for aberrant growth of cells (e.g. blebbing) in the immediate vicinity of any of the 3 
hydrogels tested. Importantly, it was ob- served that cells grew faster in antioxidant-enriched hy- 




The US Food and Drug Administration (1946) lists 2 basic requirements to be met by a biomaterial 
to dispel any doubt on “biocompatibility”: (a) security; (b) efficacy. The first requirement is satisfied by 
 
passing the test of di- rect cytotoxicity. While for the second requirement it is necessary to 
overcome a series of functionality tests de- signed to demonstrate the efficacy of the biomaterial im- 
planted. The International Organization for Standardiza- tion and the American Society for Testing 
and Materials have published a series of guidelines outlining how mate- rial biocompatibility should 
be checked using in vitro tests on cell cultures. Only after passing the various assays established for 
this phase will materials be tested in vivo on laboratory animals, followed by clinical trials in hu- 
mans. The main problem encountered in the preclinical applications of biomaterials relates to the 
verification of compatibility with the biological environment and is based on 3 main aspects: (1) 
morphological compatibility (aspect that concerns the size, shape and mass of the bio- material); 
(2) functional compatibility (aspect that con- cerns the role played by the material with respect to 
the expected role); (3) biocompatibility (takes care of the bio- material chemical and biological nature 
that can induce damaging alterations in relation to the biological sub- strate that is organ or 
tissue). We could speculate that our new type of enriched hydrogels is sufficiently flexible to adapt 
any type/shape of skin. With consideration of ste- rility, these hydrogels could potentially be used 
more eas- ily and with more efficacy than bandages as wound dress- ing for difficult wounds. The 
biocompatibility is a rather important requirement because a biomaterial must never be harmful to 
the body in which it is implanted. The target applications of the hydrogels tested in this work are 
wounds that are classified under the name of “difficult wounds” caused by burns, abrasions, and 
ulcerations [13, 17]. Also wounds due to vascular or endocrine (diabetes) disease and injury due to 
prolonged compression or forces cutting causing mechanical stress to the tissues and the 
constriction of blood vessels (bedsores). They could be nicely used for beautification. 
The concentrations of crocin and kaempferol glyco- sides used in the hydrogels were sufficiently 





We have shown that our hydrogels can be considered as delivery system for saffron-derived 
antioxidants in wound management. The cell growth of the enriched hy- drogels compared with the 
control (Fig. 1) clearly dem- onstrates the capacity of the compounds extracted from saffron petals to 
stimulate fibroblast expansion. Impor- tantly, these new types of hydrogels are easy to use and do not 
need complicated guidelines. This paves the way for applications such as wound treatment and 
wound healing correlated certainly with the cosmetic sector. As a matter of fact, worldwide the new 






These studies were supported by grants from De Montfort University, UK, and the University of 
L’Aquila, Italy. The authors are grateful to Lamberto Formiconi and the local people of Na- velli village 




Statement of Ethics 




We wish to confirm that there are no known conflicts of inter- est associated with this publication 






1. Joukar S, Ghasemipour-Afshar E, Sheibani M, Naghsh N, Bashiri A: Protective effects of 
saffron (Crocus sativus) against lethal ventric- ular arrhythmias induced by heart reperfusion in 
rat: a potential anti-arrhythmic agent. Pharm Biol 2013;51:836–843. 
2. Ohno Y, Nakanishi T, Umigai N, Tsuruma K, Shimazawa M, Hara H: Oral administration of 
crocetin prevents inner retinal damage in- duced by N-methyl-D-aspartate in mice. Eur J 
Pharmacol 2012;690:84–89. 
3. Goli SAH, Mokhtari F, Rahimmalek M: Phe- nolic compounds and antioxidant activity from 
saffron (Crocus sativus L.) petal. J Agric Sci 2012;4:175–181. 
4. Serrano-Díaz J, Estevan C, Ángel Sogorb M, Carmona M, Alonso G L, Vilanova E: Cyto- 
toxic effect against 3T3 fibroblasts cells of saf- fron floral bio-residues extracts. Food Chem 
2014;147:55–59. 
5. Moraga AR, Ahrazem O, Rambla JL, Granell A, Gomez LG: Crocins with high levels of sug- ar 
conjugation contribute to the yellow co- lours of early-spring flowering crocus petals. PLoS 
One 2013;8:e71946. 
6. Andarwulan N, Batari R, Sandrasari DA, Bol- ling B, Wijaya H: Flavonoid content and anti- 
oxidant activity of vegetables from Indonesia. Food Chem 2010;121:1231–1235. 
7. Arroo RRJ, Beresford K, Bhambra AS, Board- er M, Budriesi R, Cheng Z, Micucci M, Ru- 
parelia KC, Surichan S, Androutsopoulos VP: Phytoestrogens as natural prodrugs in cancer 
prevention: towards a mechanistic model. Phytochem Rev 2014;13:853–866. 
  
 
8. DuPont MS, Day AJ, Bennett RN, Mellon FA, Kroon PA: Absorption of kaempferol from 
endive, a source of kaempferol-3-glucuro- nide, in humans. Eur J Clin Nutr 2004;58: 947–
954. 
9. Castillo R, Fernández JA, Gómez-Gómez L: Implications of carotenoid biosynthetic genes in 
apocarotenoid formation during the stig- ma development of Crocus sativus and its closer 
relatives. Plant Physiol 2005;139:674– 689. 
10. Gutheil WG, Reed G, Ray A, Anant S, Dhar A: Crocetin: an agent derived from saffron for 
prevention and therapy for cancer. Curr Pharm Biotechnol 2012;13:173–179. 
11. Hatahet T, Morille M, Hommoss A, Devois- selle JM, Müller RH, Bégu S: Quercetin topical 
application, from conventional dosage forms to nanodosage forms. Eur J Pharm Biopharm 
2016;108:41–53. 
12. Lee KM, Lee KW, Jung SK, Lee EJ, Heo YS, Bode AM, Lubet RA, Lee HJ, Dong Z: Kaempferol 
inhibits UVB-induced COX-2 expres- sion by suppressing Src kinase activity. Bio- chem 
Pharmacol 2010;80:2042–2049. 
13. Majtan J, Bohova J, Garcia-Villalba R, Tomas- Barberan FA, Madakova Z, Majtan T, Majtan V, 
Klaudiny J: Fir honeydew honey flavonoids inhibit TNF-α-induced MMP-9 expression in human 
keratinocytes: a new action of honey in wound healing. Arch Dermatol Res 2013; 305:619–
627. 
14. Benayad Z, Gómez-Cordovés C, Es-Safi NE: Characterization of flavonoid glycosides from 
fenugreek (Trigonella foenum-graecum) crude seeds by HPLC–DAD-ESI/MS analysis. Int J Mol 
Sci 2014;15:20668–20685. 
15. Montoro P, Maldini M, Luciani L, Tuberoso CIG, Congiu F, Pizza C: Radical scavenging activity 
and LC-MS metabolic profiling of petals, stamens, and flowers of Crocus sativus L. J Food Sci 
2012;77:C893–C900. 
16. Zeka K, Ruparelia KC, Continenza MA, Sta- gos D, Vegliò F, Arroo RRJ: Petals of Crocus 
sativus L. as a potential source of the antioxi- dants crocin and kaempferol. Fitoterapia 
2015;107:128–134. 
17. Park SN, Kim SY, Lim GN, Jo NR, Lee MH: In vitro skin permeation and cellular protective effects 
of flavonoids isolated from Suaeda as- paragoides extracts. J Ind Eng Chem 2012;18: 680–683. 
18. Kropec A, Maira-Litran T, Jefferson KK, Grout M, Cramton SE, Goldmann DA, Pier GB: 
Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for viru- lence in 
murine models of systemic infection. Infect Immun 2005;10:6868–6876. 
19. Singh S: Nanomedicine-nanoscale drugs and delivery systems. J Nanosci Nanotechnol 
2010;10:7906–7918. 
20. Zhang L, Li K, Xiao W, Zheng L, Xiao Y, Fan H: Preparation of collagen-chondroitin sul- fate-




21. Bernardi S, Mummolo S, Zeka K, Pajewski L, Continenza MA, Marzo G: Use and evalua- 
tion of a cooling aid in laser-assisted dental surgery: an innovative study. Photomed Laser 
Surg 2016;34:258–262. 
22. Rosiak JM, Rucinska-Rybus A, Pekala W: Method of manufacturing of hydrogel dress- ings; 
Polish patent No 151,581, US patent No 4,871,490, Hungarian patent No 204,866, UK patent 
No. 2,200,643, German patent No 3,744,289. 1989. 
23. Goupy P, Abert Vian M, Chemat F, Caris- Veyrat C: Identification and quantification of 
flavonols, anthocyanins and lutein diesters in petals of Crocus sativus by ultra-performance 
liquid chromatography coupled to diode ar- ray and ion trap mass spectrometry detec- tions. 
Ind Crops Prod 2013;44:496–510. 
24. Termentzi A, Kokkalou E: LC-DAD-MS (ESI+) analysis and antioxidant capacity of Crocus 
sativus petal extracts. Planta Med 2008;74:573–581. 
25. Verrastro IS, Pasha KT, Pitt AR, Spicket CM: Mass spectrometry-based methods for identi- 
fying oxidized proteins in disease: advances and challenges. Biomolecules 2015; 5: 211 
378–341. 
26. Zou SB, Yoon WY, Han SK, Jeong SH, Cui ZJ, Kim WK: Cytotoxicity of silver dressings on 
diabetic fibroblasts. Int Wound J 2013;10: 306–312. 
27. Grothier L, Pardoe A: Chronic wounds: man- agement of healing and wellbeing. Br J Nurs 
2013;10;22:S24, S26–S33. 
 
 
